Such a scenario is supported by recent studies which specifically delineate the pathological mechanism whereby Grb2 promotes cardiac hypertrophy through affecting extracellular-related protein kinase signal pathway (Ganesan et al., 2013; Xia et al., 2015). Here, GRB2 is linked to cardiac hypertrophy.